Novavax stock has had a stellar run, more than doubling since early January 2021 driven by promising efficacy data for its Covid-19 vaccine. The stock is also up about 30x over the last 12 months. After such a sizable rally, is Novavax stock looking overvalued? While it's difficult to give a...
Novavax stock has had a stellar run, more than doubling since early January 2021 driven by promising efficacy data for its Covid-19 vaccine. The stock is also up about 30x over the last 12 months. After such a sizable rally, is Novavax stock looking overvalued? While it's difficult to give a...
Share this Article
Recommended